Letter to the Editor Regarding "Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial"
第一作者单位：[1]Capital Med Univ, Beijing Friendship Hosp, Dept Anesthesiol, 95 Yongan Rd, Beijing 100050, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Tan Hong,Xue Fu S.,Li Cheng W..Letter to the Editor Regarding "Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial"[J].PAIN AND THERAPY.2022,doi:10.1007/s40122-022-00414-9.
APA：
Tan, Hong,Xue, Fu S.&Li, Cheng W..(2022).Letter to the Editor Regarding "Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial".PAIN AND THERAPY,,
MLA：
Tan, Hong,et al."Letter to the Editor Regarding "Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial"".PAIN AND THERAPY .(2022)
